Publication:
Survival outcome of combined gnrh agonist and tamoxifen is comparable to that of sequential adriamycin and cyclophosphamide chemotherapy plus tamoxifen in premenopausal patients with early breast cancer

Suggested Citation

Doonyapat Sa-Nguanraksa, Thitikon Krisorakun, Wanee Pongthong, Pornchai O-Charoenrat Survival outcome of combined gnrh agonist and tamoxifen is comparable to that of sequential adriamycin and cyclophosphamide chemotherapy plus tamoxifen in premenopausal patients with early breast cancer. Molecular and Clinical Oncology. Vol.11, No.5 (2019), 517-522. doi:10.3892/mco.2019.1913 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/50043

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Availability

Collections